Featured Pharma Online Editorial
-
5 Proven Steps To Successfully Select & Onboard Outsourced Logistics Partners
1/23/2017
In preceding articles in this series, we reviewed some of the challenges and remediation approaches for the storage and distribution of life science products, highlighting some of the specific risks related to storage, transportation, and material control across an extended chain of custody. This brings us to the final article, in which we will discuss best practices for selecting the partners that will be an extension of your staff for monitoring and control across an ever-changing global landscape.
-
2nd Draft Guidance Under DSCSA Offers Clarity For 3PLs As January Deadline Approaches
10/28/2014
Earlier this month, the FDA announced the availability of the second draft guidance under the Drug Supply Chain Security Act (DSCSA), titled The Effect of Section 585 of the FD&C Act on Drug Product Tracing and Wholesale Drug Distributor and Third-Party Logistics Provider Licensing Standards and Requirements: Questions and Answers. While clarifying information is provided, the guidance is still in draft form and more information from industry will need to be collected in order to drive it to a finalized state.
-
The Difference Between Logistics Management And Logistics Control In Life Sciences
5/11/2013
Life science products have a distinct logistical profile; the nuances between a fine chemical and a medical compound or medical devices and computer hardware have significant regulatory differences. When determining the logistics plan for a product it is critical to remember that it is not just a box. By Paddy Hanlon, Senior Director, Business Development, Marken